The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Prenatal Second-Generation DNA Sequencing Market Research Report 2025

Global Prenatal Second-Generation DNA Sequencing Market Research Report 2025

Publishing Date : Apr, 2025

License Type :
 

Report Code : 2004770

No of Pages : 110

Ask Your Query
Synopsis
The global market for Prenatal Second-Generation DNA Sequencing was valued at US$ 1290 million in the year 2024 and is projected to reach a revised size of US$ 2458 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Prenatal second-generation DNA sequencing refers to the cutting-edge prenatal screening method that uses high-throughput sequencing technology to analyze fetal free DNA in the peripheral blood of pregnant women, in order to detect fetal chromosomal abnormalities and genetic diseases. Compared to invasive examinations such as amniocentesis, this method has significant advantages of non invasiveness and high safety. In terms of clinical application, prenatal second-generation DNA sequencing has expanded from the initial screening for Down syndrome to include screening for sex chromosome abnormalities (such as Turner syndrome, Klinefelter syndrome), microdeletion/microduplication syndrome (such as 22q11.2 deletion syndrome), and some monogenic genetic diseases.
The global market for prenatal second-generation DNA sequencing has shown a thriving trend in recent years. The main driving factors include technological innovation and cost reduction, policy environment optimization, consumer awareness enhancement, and the favor of the capital market. The North American market currently holds a dominant position globally, and its rapid development is attributed to comprehensive healthcare coverage, high medical expenses, and strong consumer demand for advanced prenatal screening. European countries generally adopt strict regulatory policies for prenatal genetic testing, but the market still maintains stable growth under the promotion of precision medicine strategies. The Asia Pacific region has the fastest market growth, mainly driven by policy support, healthcare system upgrades, and other factors. The market competition presents the characteristics of globalization and regionalization coexisting, and various enterprises have adopted differentiated competition strategies based on their own advantages. International leading companies such as Roche, Natera, and Illumina dominate in technology and market, while domestic companies such as BGI Genomics, Berry Genomics, and DAAN Gene are also rapidly rising and actively participating in international competition. In the future, the development trend of the industry mainly lies in the expansion of detection scope, integration of multiple omics, intelligent application of data, forward movement of application scenarios, market segmentation and differentiation, and parallel development of globalization and localization. The market for prenatal second-generation DNA sequencing will enter a mature development stage, with a possible slowdown in growth but deeper applications. Leading enterprises need to shift from technology driven to value driven, not only demonstrating the technical feasibility of testing, but also proving its clinical utility and health economics value. The industry will also face deepening ethical considerations, and how to strike a balance between technological progress and humanistic care will become a proposition that all market participants must consider.
This report aims to provide a comprehensive presentation of the global market for Prenatal Second-Generation DNA Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prenatal Second-Generation DNA Sequencing.
The Prenatal Second-Generation DNA Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prenatal Second-Generation DNA Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prenatal Second-Generation DNA Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Natera
Illumina
Quest Diagnostics
Ambry Genetics
PerkinEImer
Invitae
Neogenomics
Agilent Technologies
Sema4
Thermo Fisher Scientific
Fulgent Genetics
Genomics England
BGI Genomics
Berry Genomics
DAAN Gene
CapitalBio
Annoroad
MGI Tech
FANdi Biotechnology
BioMiao Biotechnology
JBP Medical
Segment by Type
Genome Sequencing
Targeted Sequencing
Segment by Application
High-Risk Pregnant Women Screening
Twin Pregnancy
Assisted Reproductive Technology Pregnancy
Low-Risk Pregnant Women Screening
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prenatal Second-Generation DNA Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genome Sequencing
1.2.3 Targeted Sequencing
1.3 Market by Application
1.3.1 Global Prenatal Second-Generation DNA Sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 High-Risk Pregnant Women Screening
1.3.3 Twin Pregnancy
1.3.4 Assisted Reproductive Technology Pregnancy
1.3.5 Low-Risk Pregnant Women Screening
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prenatal Second-Generation DNA Sequencing Market Perspective (2020-2031)
2.2 Global Prenatal Second-Generation DNA Sequencing Growth Trends by Region
2.2.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prenatal Second-Generation DNA Sequencing Historic Market Size by Region (2020-2025)
2.2.3 Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Region (2026-2031)
2.3 Prenatal Second-Generation DNA Sequencing Market Dynamics
2.3.1 Prenatal Second-Generation DNA Sequencing Industry Trends
2.3.2 Prenatal Second-Generation DNA Sequencing Market Drivers
2.3.3 Prenatal Second-Generation DNA Sequencing Market Challenges
2.3.4 Prenatal Second-Generation DNA Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prenatal Second-Generation DNA Sequencing Players by Revenue
3.1.1 Global Top Prenatal Second-Generation DNA Sequencing Players by Revenue (2020-2025)
3.1.2 Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global Top Prenatal Second-Generation DNA Sequencing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prenatal Second-Generation DNA Sequencing Revenue
3.4 Global Prenatal Second-Generation DNA Sequencing Market Concentration Ratio
3.4.1 Global Prenatal Second-Generation DNA Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prenatal Second-Generation DNA Sequencing Revenue in 2024
3.5 Global Key Players of Prenatal Second-Generation DNA Sequencing Head office and Area Served
3.6 Global Key Players of Prenatal Second-Generation DNA Sequencing, Product and Application
3.7 Global Key Players of Prenatal Second-Generation DNA Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prenatal Second-Generation DNA Sequencing Breakdown Data by Type
4.1 Global Prenatal Second-Generation DNA Sequencing Historic Market Size by Type (2020-2025)
4.2 Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Type (2026-2031)
5 Prenatal Second-Generation DNA Sequencing Breakdown Data by Application
5.1 Global Prenatal Second-Generation DNA Sequencing Historic Market Size by Application (2020-2025)
5.2 Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prenatal Second-Generation DNA Sequencing Market Size (2020-2031)
6.2 North America Prenatal Second-Generation DNA Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025)
6.4 North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prenatal Second-Generation DNA Sequencing Market Size (2020-2031)
7.2 Europe Prenatal Second-Generation DNA Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025)
7.4 Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size (2020-2031)
8.2 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prenatal Second-Generation DNA Sequencing Market Size (2020-2031)
9.2 Latin America Prenatal Second-Generation DNA Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025)
9.4 Latin America Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size (2020-2031)
10.2 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Prenatal Second-Generation DNA Sequencing Introduction
11.1.4 Roche Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Natera
11.2.1 Natera Company Details
11.2.2 Natera Business Overview
11.2.3 Natera Prenatal Second-Generation DNA Sequencing Introduction
11.2.4 Natera Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.2.5 Natera Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Prenatal Second-Generation DNA Sequencing Introduction
11.3.4 Illumina Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.3.5 Illumina Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Details
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Introduction
11.4.4 Quest Diagnostics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.4.5 Quest Diagnostics Recent Development
11.5 Ambry Genetics
11.5.1 Ambry Genetics Company Details
11.5.2 Ambry Genetics Business Overview
11.5.3 Ambry Genetics Prenatal Second-Generation DNA Sequencing Introduction
11.5.4 Ambry Genetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.5.5 Ambry Genetics Recent Development
11.6 PerkinEImer
11.6.1 PerkinEImer Company Details
11.6.2 PerkinEImer Business Overview
11.6.3 PerkinEImer Prenatal Second-Generation DNA Sequencing Introduction
11.6.4 PerkinEImer Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.6.5 PerkinEImer Recent Development
11.7 Invitae
11.7.1 Invitae Company Details
11.7.2 Invitae Business Overview
11.7.3 Invitae Prenatal Second-Generation DNA Sequencing Introduction
11.7.4 Invitae Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.7.5 Invitae Recent Development
11.8 Neogenomics
11.8.1 Neogenomics Company Details
11.8.2 Neogenomics Business Overview
11.8.3 Neogenomics Prenatal Second-Generation DNA Sequencing Introduction
11.8.4 Neogenomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.8.5 Neogenomics Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Prenatal Second-Generation DNA Sequencing Introduction
11.9.4 Agilent Technologies Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.9.5 Agilent Technologies Recent Development
11.10 Sema4
11.10.1 Sema4 Company Details
11.10.2 Sema4 Business Overview
11.10.3 Sema4 Prenatal Second-Generation DNA Sequencing Introduction
11.10.4 Sema4 Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.10.5 Sema4 Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Introduction
11.11.4 Thermo Fisher Scientific Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Fulgent Genetics
11.12.1 Fulgent Genetics Company Details
11.12.2 Fulgent Genetics Business Overview
11.12.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Introduction
11.12.4 Fulgent Genetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.12.5 Fulgent Genetics Recent Development
11.13 Genomics England
11.13.1 Genomics England Company Details
11.13.2 Genomics England Business Overview
11.13.3 Genomics England Prenatal Second-Generation DNA Sequencing Introduction
11.13.4 Genomics England Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.13.5 Genomics England Recent Development
11.14 BGI Genomics
11.14.1 BGI Genomics Company Details
11.14.2 BGI Genomics Business Overview
11.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Introduction
11.14.4 BGI Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.14.5 BGI Genomics Recent Development
11.15 Berry Genomics
11.15.1 Berry Genomics Company Details
11.15.2 Berry Genomics Business Overview
11.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Introduction
11.15.4 Berry Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.15.5 Berry Genomics Recent Development
11.16 DAAN Gene
11.16.1 DAAN Gene Company Details
11.16.2 DAAN Gene Business Overview
11.16.3 DAAN Gene Prenatal Second-Generation DNA Sequencing Introduction
11.16.4 DAAN Gene Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.16.5 DAAN Gene Recent Development
11.17 CapitalBio
11.17.1 CapitalBio Company Details
11.17.2 CapitalBio Business Overview
11.17.3 CapitalBio Prenatal Second-Generation DNA Sequencing Introduction
11.17.4 CapitalBio Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.17.5 CapitalBio Recent Development
11.18 Annoroad
11.18.1 Annoroad Company Details
11.18.2 Annoroad Business Overview
11.18.3 Annoroad Prenatal Second-Generation DNA Sequencing Introduction
11.18.4 Annoroad Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.18.5 Annoroad Recent Development
11.19 MGI Tech
11.19.1 MGI Tech Company Details
11.19.2 MGI Tech Business Overview
11.19.3 MGI Tech Prenatal Second-Generation DNA Sequencing Introduction
11.19.4 MGI Tech Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.19.5 MGI Tech Recent Development
11.20 FANdi Biotechnology
11.20.1 FANdi Biotechnology Company Details
11.20.2 FANdi Biotechnology Business Overview
11.20.3 FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Introduction
11.20.4 FANdi Biotechnology Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.20.5 FANdi Biotechnology Recent Development
11.21 BioMiao Biotechnology
11.21.1 BioMiao Biotechnology Company Details
11.21.2 BioMiao Biotechnology Business Overview
11.21.3 BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Introduction
11.21.4 BioMiao Biotechnology Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.21.5 BioMiao Biotechnology Recent Development
11.22 JBP Medical
11.22.1 JBP Medical Company Details
11.22.2 JBP Medical Business Overview
11.22.3 JBP Medical Prenatal Second-Generation DNA Sequencing Introduction
11.22.4 JBP Medical Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
11.22.5 JBP Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Genome Sequencing
Table 3. Key Players of Targeted Sequencing
Table 4. Global Prenatal Second-Generation DNA Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Prenatal Second-Generation DNA Sequencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Prenatal Second-Generation DNA Sequencing Market Share by Region (2020-2025)
Table 8. Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Prenatal Second-Generation DNA Sequencing Market Share by Region (2026-2031)
Table 10. Prenatal Second-Generation DNA Sequencing Market Trends
Table 11. Prenatal Second-Generation DNA Sequencing Market Drivers
Table 12. Prenatal Second-Generation DNA Sequencing Market Challenges
Table 13. Prenatal Second-Generation DNA Sequencing Market Restraints
Table 14. Global Prenatal Second-Generation DNA Sequencing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Prenatal Second-Generation DNA Sequencing Market Share by Players (2020-2025)
Table 16. Global Top Prenatal Second-Generation DNA Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal Second-Generation DNA Sequencing as of 2024)
Table 17. Ranking of Global Top Prenatal Second-Generation DNA Sequencing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Prenatal Second-Generation DNA Sequencing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Prenatal Second-Generation DNA Sequencing, Headquarters and Area Served
Table 20. Global Key Players of Prenatal Second-Generation DNA Sequencing, Product and Application
Table 21. Global Key Players of Prenatal Second-Generation DNA Sequencing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prenatal Second-Generation DNA Sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Type (2020-2025)
Table 25. Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Type (2026-2031)
Table 27. Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Application (2020-2025)
Table 29. Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Application (2026-2031)
Table 31. North America Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Roche Company Details
Table 47. Roche Business Overview
Table 48. Roche Prenatal Second-Generation DNA Sequencing Product
Table 49. Roche Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Natera Company Details
Table 52. Natera Business Overview
Table 53. Natera Prenatal Second-Generation DNA Sequencing Product
Table 54. Natera Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 55. Natera Recent Development
Table 56. Illumina Company Details
Table 57. Illumina Business Overview
Table 58. Illumina Prenatal Second-Generation DNA Sequencing Product
Table 59. Illumina Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 60. Illumina Recent Development
Table 61. Quest Diagnostics Company Details
Table 62. Quest Diagnostics Business Overview
Table 63. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product
Table 64. Quest Diagnostics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 65. Quest Diagnostics Recent Development
Table 66. Ambry Genetics Company Details
Table 67. Ambry Genetics Business Overview
Table 68. Ambry Genetics Prenatal Second-Generation DNA Sequencing Product
Table 69. Ambry Genetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 70. Ambry Genetics Recent Development
Table 71. PerkinEImer Company Details
Table 72. PerkinEImer Business Overview
Table 73. PerkinEImer Prenatal Second-Generation DNA Sequencing Product
Table 74. PerkinEImer Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 75. PerkinEImer Recent Development
Table 76. Invitae Company Details
Table 77. Invitae Business Overview
Table 78. Invitae Prenatal Second-Generation DNA Sequencing Product
Table 79. Invitae Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 80. Invitae Recent Development
Table 81. Neogenomics Company Details
Table 82. Neogenomics Business Overview
Table 83. Neogenomics Prenatal Second-Generation DNA Sequencing Product
Table 84. Neogenomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 85. Neogenomics Recent Development
Table 86. Agilent Technologies Company Details
Table 87. Agilent Technologies Business Overview
Table 88. Agilent Technologies Prenatal Second-Generation DNA Sequencing Product
Table 89. Agilent Technologies Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 90. Agilent Technologies Recent Development
Table 91. Sema4 Company Details
Table 92. Sema4 Business Overview
Table 93. Sema4 Prenatal Second-Generation DNA Sequencing Product
Table 94. Sema4 Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 95. Sema4 Recent Development
Table 96. Thermo Fisher Scientific Company Details
Table 97. Thermo Fisher Scientific Business Overview
Table 98. Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Product
Table 99. Thermo Fisher Scientific Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 100. Thermo Fisher Scientific Recent Development
Table 101. Fulgent Genetics Company Details
Table 102. Fulgent Genetics Business Overview
Table 103. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product
Table 104. Fulgent Genetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 105. Fulgent Genetics Recent Development
Table 106. Genomics England Company Details
Table 107. Genomics England Business Overview
Table 108. Genomics England Prenatal Second-Generation DNA Sequencing Product
Table 109. Genomics England Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 110. Genomics England Recent Development
Table 111. BGI Genomics Company Details
Table 112. BGI Genomics Business Overview
Table 113. BGI Genomics Prenatal Second-Generation DNA Sequencing Product
Table 114. BGI Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 115. BGI Genomics Recent Development
Table 116. Berry Genomics Company Details
Table 117. Berry Genomics Business Overview
Table 118. Berry Genomics Prenatal Second-Generation DNA Sequencing Product
Table 119. Berry Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 120. Berry Genomics Recent Development
Table 121. DAAN Gene Company Details
Table 122. DAAN Gene Business Overview
Table 123. DAAN Gene Prenatal Second-Generation DNA Sequencing Product
Table 124. DAAN Gene Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 125. DAAN Gene Recent Development
Table 126. CapitalBio Company Details
Table 127. CapitalBio Business Overview
Table 128. CapitalBio Prenatal Second-Generation DNA Sequencing Product
Table 129. CapitalBio Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 130. CapitalBio Recent Development
Table 131. Annoroad Company Details
Table 132. Annoroad Business Overview
Table 133. Annoroad Prenatal Second-Generation DNA Sequencing Product
Table 134. Annoroad Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 135. Annoroad Recent Development
Table 136. MGI Tech Company Details
Table 137. MGI Tech Business Overview
Table 138. MGI Tech Prenatal Second-Generation DNA Sequencing Product
Table 139. MGI Tech Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 140. MGI Tech Recent Development
Table 141. FANdi Biotechnology Company Details
Table 142. FANdi Biotechnology Business Overview
Table 143. FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Product
Table 144. FANdi Biotechnology Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 145. FANdi Biotechnology Recent Development
Table 146. BioMiao Biotechnology Company Details
Table 147. BioMiao Biotechnology Business Overview
Table 148. BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Product
Table 149. BioMiao Biotechnology Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 150. BioMiao Biotechnology Recent Development
Table 151. JBP Medical Company Details
Table 152. JBP Medical Business Overview
Table 153. JBP Medical Prenatal Second-Generation DNA Sequencing Product
Table 154. JBP Medical Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)
Table 155. JBP Medical Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
Table 159. Authors List of This Report


List of Figures
Figure 1. Prenatal Second-Generation DNA Sequencing Picture
Figure 2. Global Prenatal Second-Generation DNA Sequencing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Prenatal Second-Generation DNA Sequencing Market Share by Type: 2024 VS 2031
Figure 4. Genome Sequencing Features
Figure 5. Targeted Sequencing Features
Figure 6. Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Prenatal Second-Generation DNA Sequencing Market Share by Application: 2024 VS 2031
Figure 8. High-Risk Pregnant Women Screening Case Studies
Figure 9. Twin Pregnancy Case Studies
Figure 10. Assisted Reproductive Technology Pregnancy Case Studies
Figure 11. Low-Risk Pregnant Women Screening Case Studies
Figure 12. Others Case Studies
Figure 13. Prenatal Second-Generation DNA Sequencing Report Years Considered
Figure 14. Global Prenatal Second-Generation DNA Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Prenatal Second-Generation DNA Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Prenatal Second-Generation DNA Sequencing Market Share by Region: 2024 VS 2031
Figure 17. Global Prenatal Second-Generation DNA Sequencing Market Share by Players in 2024
Figure 18. Global Prenatal Second-Generation DNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Prenatal Second-Generation DNA Sequencing Revenue in 2024
Figure 20. North America Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Prenatal Second-Generation DNA Sequencing Market Share by Country (2020-2031)
Figure 22. United States Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Prenatal Second-Generation DNA Sequencing Market Share by Country (2020-2031)
Figure 26. Germany Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Share by Region (2020-2031)
Figure 34. China Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Prenatal Second-Generation DNA Sequencing Market Share by Country (2020-2031)
Figure 42. Mexico Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Share by Country (2020-2031)
Figure 46. Turkey Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Roche Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 50. Natera Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 51. Illumina Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 52. Quest Diagnostics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 53. Ambry Genetics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 54. PerkinEImer Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 55. Invitae Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 56. Neogenomics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 57. Agilent Technologies Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 58. Sema4 Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 60. Fulgent Genetics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 61. Genomics England Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 62. BGI Genomics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 63. Berry Genomics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 64. DAAN Gene Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 65. CapitalBio Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 66. Annoroad Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 67. MGI Tech Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 68. FANdi Biotechnology Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 69. BioMiao Biotechnology Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 70. JBP Medical Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock